Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum
2018 · Genetics in Medicine · 150 citations
https://doi.org/10.1038/s41436-018-0297-9
R
Romaric Loffroy
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
136
Papers
3.5K
Citations
24
h-index
51
i10-index
Romaric Loffroy is an academic researcher from Maison des Sciences sociales et des Humanités de Dijon. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Liver Disease Diagnosis and Treatment & MRI in cancer diagnosis. The author has an h-index of 24, co-authored 116 publications.
Papers by this author
worksShort-term Safety and Quality of Life Outcomes Following Radioembolization in Primary and Secondary Liver Tumours: a Multi-centre Analysis of 200 Patients in France
2020 · CardioVascular and Interventional Radiology · 23 citations
https://doi.org/10.1007/s00270-020-02643-x
Safety and efficacy of low-dose PI3K inhibitor taselisib in adult patients with CLOVES and Klippel–Trenaunay syndrome (KTS): the TOTEM trial, a phase 1/2 multicenter, open-label, single-arm study
2021 · Genetics in Medicine · 21 citations
https://doi.org/10.1038/s41436-021-01290-y
Health-related quality of life in locally advanced hepatocellular carcinoma treated by either radioembolisation or sorafenib (SARAH trial)
2021 · European Journal of Cancer · 18 citations
https://doi.org/10.1016/j.ejca.2021.05.032
CIRSE Standards of Practice on Transjugular Intrahepatic Portosystemic Shunts
2024 · CardioVascular and Interventional Radiology · 17 citations
https://doi.org/10.1007/s00270-024-03866-y
Incremental value of the combined brain-cardiac CT protocol on prediction of atrial fibrillation after stroke
2022 · European Stroke Journal · 12 citations
https://doi.org/10.1177/23969873221138197
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat